posted on 2020-04-02, 16:05authored byChristoph Enzensperger, Franziska K. U. Müller, Bärbel Schmalwasser, Petra Wiecha, Heidi Traber, Jochen Lehmann
Oxygenated 7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecines are potent dopamine receptor antagonists,
preferentially at D1/D5. We synthesized the hydroxylated, methoxylated, and chlorinated 11-membered and
12-membered homologues of these 10-membered heterocycles. Their affinities for the human cloned D1−D5 receptors (radioligand binding) and functionalities (calcium assay) were measured. Enlarging the
dibenzazecines to the corresponding dibenzazacycloundecenes and dibenzazacyclododecenes generally
maintains the high antagonistic affinity for D1/D5 but also leads to a compound with a clozapine-like binding
profile due to additional affinity for D4.